Preparing for the incoming wave of biosimilars in oncology

With the imminent arrival of oncology biosimilars in the therapeutic paradigm, stakeholders including a clinician, specialist nurse, patient advocate, regulator and economist provide their perspective on optimising the uptake of these new agents in the treatment of cancer. A number of key messages e...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolff-Holz, Elena, Garcia Burgos, Juan, Giuliani, Rosa, Befrits, Gustaf, de Munter, Johan, Avedano, Luisa, Aitken, Murray, Gonzalez-Quevedo, Rosa, Vyas, Malvika, de Vries, Elisabeth G E, Tabernero, Josep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144900/
https://www.ncbi.nlm.nih.gov/pubmed/30245864
http://dx.doi.org/10.1136/esmoopen-2018-000420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144900/
https://www.ncbi.nlm.nih.gov/pubmed/30245864
http://dx.doi.org/10.1136/esmoopen-2018-000420

Ejemplares similares